RECRUITING

DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support with Technology for Latinx Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The specific aims of this project are to culturally adapt the DM-BOOST intervention for Latinx patients, usability test 'DM-BOOST para Latinx' to optimize cultural appropriateness and patient engagement and conduct a feasibility evaluation of DM-BOOST para Latinx. These aims will be accomplished via a community-based participatory research approach in collaboration with clinical, community and patient partners. This project will inform subsequent proposals to evaluate implementation of DM-BOOST in the UMass Memorial Health Care system.

Official Title

DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support with Technology for Latinx Patients

Quick Facts

Study Start:2024-12-01
Study Completion:2025-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05583877

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age \> 18 years
  2. * Diagnosis of type 2 diabetes
  3. * Identifies as Hispanic/Latinx
  4. * Spanish language preference
  1. * Cognitive impairment
  2. * Current prisoner
  3. * Pregnant women

Contacts and Locations

Study Contact

Daniel J Amante, PhD, MPH
CONTACT
508-856-8480
daniel.amante@umassmed.edu

Principal Investigator

Daniel J Amante, PhD, MPH
PRINCIPAL_INVESTIGATOR
UMass Chan Medical School

Study Locations (Sites)

UMass Memorial health
Worcester, Massachusetts, 01605
United States
University of Massachusetts Medical School
Worcester, Massachusetts, 01655
United States

Collaborators and Investigators

Sponsor: Daniel Amante

  • Daniel J Amante, PhD, MPH, PRINCIPAL_INVESTIGATOR, UMass Chan Medical School

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-01
Study Completion Date2025-05-01

Study Record Updates

Study Start Date2024-12-01
Study Completion Date2025-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 2